Correlation Between Smith Nephew and Edwards Lifesciences

Can any of the company-specific risk be diversified away by investing in both Smith Nephew and Edwards Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Smith Nephew and Edwards Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Smith Nephew SNATS and Edwards Lifesciences Corp, you can compare the effects of market volatilities on Smith Nephew and Edwards Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Smith Nephew with a short position of Edwards Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Smith Nephew and Edwards Lifesciences.

Diversification Opportunities for Smith Nephew and Edwards Lifesciences

-0.1

Correlation Coefficient

Smith Nephew  Edwards Lifesciences

Good diversification

The 3 months correlation between Smith and Edwards is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Smith Nephew SNATS and Edwards Lifesciences Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edwards Lifesciences Corp and Smith Nephew is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Smith Nephew SNATS are associated (or correlated) with Edwards Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edwards Lifesciences Corp has no effect on the direction of Smith Nephew i.e., Smith Nephew and Edwards Lifesciences go up and down completely randomly.

Pair Corralation between Smith Nephew and Edwards Lifesciences

Considering the 90-day investment horizon Smith Nephew SNATS is expected to under-perform the Edwards Lifesciences. In addition to that, Smith Nephew is 1.33 times more volatile than Edwards Lifesciences Corp. It trades about -0.12 of its total potential returns per unit of risk. Edwards Lifesciences Corp is currently generating about 0.06 per unit of volatility. If you would invest  6,875  in Edwards Lifesciences Corp on August 31, 2024 and sell it today you would earn a total of  332.00  from holding Edwards Lifesciences Corp or generate 4.83% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Smith Nephew SNATS  vs.  Edwards Lifesciences Corp

Smith Nephew SNATS

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Smith Nephew SNATS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Edwards Lifesciences Corp

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Edwards Lifesciences Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Edwards Lifesciences is not utilizing all of its potentials. The newest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Smith Nephew and Edwards Lifesciences

The main advantage of trading using opposite Smith Nephew and Edwards Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Smith Nephew position performs unexpectedly, Edwards Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will offset losses from the drop in Edwards Lifesciences' long position.

The idea behind Smith Nephew SNATS and Edwards Lifesciences Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.